Keyphrases
American Academy of Sleep Medicine
7%
Anxiety Disorders
14%
Apnea-hypopnea Index
8%
Benzodiazepine Receptor Agonists
15%
Caffeine
7%
Chronic Insomnia
32%
Chronic Insomnia Disorder
7%
Cognitive Behavioral Therapy
12%
Cognitive Impairment
7%
Daytime Sleep
9%
Daytime Sleepiness
14%
End User Searching
14%
Evidence-based
8%
Excessive Daytime Sleepiness
16%
Healthcare Professionals
10%
Indiplon
15%
Insomnia
100%
Insomnia Disorder
9%
Insomnia Medications
9%
Insomnia Treatment
32%
Marijuana
7%
Mental Disorders
14%
Modified Release
8%
Mood Disorders
14%
Narcolepsy
11%
Non-benzodiazepine
12%
Objective Sleep
14%
Optimal Treatment
7%
Orexin Receptors
8%
Pharmacodynamics
12%
Pharmacologic
7%
Pharmacological Therapy
15%
Pharmacotherapeutic Approaches
7%
Polysomnography
9%
Psychiatric Disorders
28%
Psychiatric Illness
16%
Ramelteon
10%
Rapid Eye Movement Sleep
7%
Sleep Characteristics
14%
Sleep Disorders
26%
Sleep Disturbance
29%
Sleep Medicine
9%
Sleep Onset
11%
Sleep Problems
21%
Sleep-disordered Breathing
14%
Snoring
7%
Subjective Sleep
14%
Survival Analysis
7%
Suvorexant
8%
United States
10%
Neuroscience
Agonist
23%
Almorexant
7%
Antidepressant
7%
Antidepressant Therapy
7%
Antihistamines
7%
Anxiety Disorder
7%
Behavior (Neuroscience)
14%
Behavioral Therapy
7%
Benzodiazepine
14%
Benzodiazepine Receptor
17%
Cannabis
14%
Circadian Rhythm
21%
Cognitive Behavioral Therapy
14%
Daytime Somnolence
11%
Decision-Making Process
7%
Dietary Supplement
7%
Doxepin
7%
Dual Orexin Receptor Antagonist
7%
Eszopiclone
21%
Gamma-Aminobutyric Acid
10%
Histamine Receptor
7%
Hypersomnia
7%
Hypnotic
21%
Melatonin
7%
Melatonin 1 Receptor
5%
Melatonin 2 Receptor
5%
Melatonin Receptor Agonist
12%
Mental Disorder
10%
Mood Disorder
7%
Nonbenzodiazepine
7%
Obstructive Sleep Apnea
14%
Opiate
7%
Orexin
8%
Pharmacokinetics
22%
Primary Insomnia
8%
Ramelteon
14%
Rapid Eye Movement Sleep
7%
Receptor Agonists
28%
Receptor Antagonist
8%
Sleep
7%
Sleep Disorder
84%
Sleep Time
17%
Stereotypic Movement Disorder
7%
Suvorexant
7%
Tasimelteon
7%
Typical Antipsychotic
7%
Z-Drug
7%
Zaleplon
14%
Zolpidem
21%
Pharmacology, Toxicology and Pharmaceutical Science
4 Aminobutyric Acid
14%
Adverse Event
10%
Almorexant
7%
Antidepressant
10%
Antihistaminic Agent
12%
Apnea
5%
Benzodiazepine
8%
Benzodiazepine Receptor Stimulating Agent
36%
Cataplexy
8%
Clinical Trial
9%
Combination Therapy
7%
Daytime Somnolence
6%
Disease
41%
Eszopiclone
16%
Histamine Agonist
7%
Hypnotic
28%
Indiplon
14%
Medical History
7%
Melatonin
10%
Melatonin Receptor Agonist
25%
Mood Disorder
7%
Narcolepsy
11%
Neurologic Disease
8%
Nonbenzodiazepine
7%
Orexin
13%
Orexin Receptor Antagonist
8%
Pharmacodynamics
27%
Pharmacokinetics
29%
Pharmacotherapy
7%
Ramelteon
17%
Sleep Disorder
63%
Sleep Disordered Breathing
25%
Sodium Oxybate
7%
Suvorexant
9%
Symptom
13%
Tablet
13%
Typical Antipsychotic
11%
Zaleplon
9%
Zolpidem
27%
Zolpidem Tartrate
7%